Professor of Radiation Oncology, University Fla College of Medicine
Radiation Oncology
Dr. William M. Mendenhall, MD
|
|
Give Review
William M. Mendenhall works in the field of Radiation Oncology. He studied medicine at University of South Florida College of Medicine. University of South Florida College of Medicine is ranked 79/85 in Research/PrimaryCare. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Men's Health" and "Top Doctors: Florida". William M. Mendenhall is also a published doctor. He has 99 paper published. The most recent paper is: Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound. Doctor William M. Mendenhall, MD accepts Medicare.
Publications
- Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
- Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.
- Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?
- Radiation therapy for nasal vestibule squamous cell carcinoma: a 40-year experience.
- Clinical and Radiographic Response With Combined BRAF-Targeted Therapy in Stage 4 Ameloblastoma.
- Challenging the need for random directed biopsies of the nasopharynx, pyriform sinus, and contralateral tonsil in the work up of unknown primary squamous cell carcinom...
- Radiotherapy for benign Head and neck paragangliomas: A 45-year experience.
- Rectal Toxicity After Proton Therapy For Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted at the University of Florida Proton Therapy Institute.
- Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.
- Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma.
- RTOG 9003: The Untold Story.
- Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery: a 10-year update.
- Update on primary Head and neck mucosal melanoma.
- Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma.
- Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
- Salivary mucoepidermoid carcinoma revisited.
- Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate Cancer.
- When is chemotherapy in Head and neck squamous cell carcinoma not indicated?
- Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute.
- Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal Cancer.
- Hemorrhagic Radiation Cystitis.
- Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate Cancer.
- Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
- Radiotherapy for sinonasal undifferentiated carcinoma.
- When is radiation therapy in Head and neck squamous cell carcinoma not indicated?
- Impact of primary tumor volume on local control after definitive radiotherapy for Head and neck cancer.
- Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy.
- Esthesioneuroblastoma of the Nasal Cavity.
- Clival chordomas: A pathological, surgical, and radiotherapeutic review.
- Airway issues in anaplastic thyroid carcinoma.
- Impact of Radiographic Findings on For Prognosis Skin Cancer With Perineural Invasion.
- Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate Cancer is not associated with post-treatment testosterone suppression.
- Radiation Therapy for Mucosal Melanoma of the Head and Neck.
- Outcomes in men with large prostates (? 60 cm(3)) treated with definitive proton therapy for prostate Cancer.
- Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate Cancer: Results of two prospective trials.
- Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.
- Radiotherapy for Dermatofibrosarcoma Protuberans.
- Radiotherapy Alone or Combined With Chemotherapy for the Treatment of Squamous Cell Carcinoma of the Base of the Tongue.
- Polymorphous Low-grade Adenocarcinoma of the Head and Neck.
- Mohs resection and postoperative radiotherapy for Head and neck cancers with incidental perineural invasion.
- Elective Neck management for high-grade salivary gland carcinoma.
- Hip fractures and pain following proton therapy for management of prostate Cancer.
- Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
- Management of Radiation Proctitis.
- Radiation Therapy for Hemangioendothelioma: The University of Florida Experience.
- Transanal Excision with Radiation Therapy for Rectal Adenocarcinoma.
- Radiotherapy for pleomorphic adenoma.
- Submandibular Gland-sparing Intensity-modulated Radiotherapy.
- Radiotherapy in the Management of Giant Cell Tumor of Bone.
- Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy.
- Cutaneous Head and neck basal and squamous cell carcinomas with perineural invasion.
- Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: A randomized study.
- Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate Cancer in men 60 years old and younger.
- When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?
- Adenoid cystic carcinoma of the Head and neck.
- Skin carcinoma of the Head and neck with perineural invasion.
- Contemporary management of lymph node metastases from an unknown primary to the Neck: I. A review of diagnostic approaches.
- Head and neck paragangliomas.
- Severe Dry Eye Syndrome After Radiotherapy for Head-and-Neck Tumors.
- Cutaneous Merkel cell carcinoma.
- Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer.
- Fractionated Radiotherapy in the Management of Benign Vascular Tumors.
- Elective Neck dissection for second primary after previous definitive radiotherapy.
- Proton therapy for prostate Cancer.
- Proton Radiotherapy for Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression.
- Human papillomavirus, smoking, and Head and neck cancer.
- Evidence for treatment strategies in sinonasal adenocarcinoma.
- Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy.
- Radiotherapy With or Without Surgery for Maxillary Sinus Squamous Cell Carcinoma: Should the Clinical N0 Neck be Treated?
- Radiation therapy for management of t1-t2 glottic Cancer at a private practice.
- Head and neck osteosarcoma.
- Early outcomes from three prospective trials of image-guided proton therapy for prostate Cancer.
- Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
- Impact of Salivary Gland Dosimetry on Post-IMRT Recovery of Saliva Output and Xerostomia Grade for Head-and-Neck Cancer Patients Treated with or without Contralateral ...
- T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
- Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced Head and neck cancer.
- Is radical prostatectomy the 'gold standard' for localized prostate Cancer?
- Squamous Cell Carcinoma of the Anal Margin: The University of Florida Experience.
- Head and neck squamous cell carcinoma from an unknown primary site.
- Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord.
- Ewing tumors of the Head and neck.
- Altered fractionation and adjuvant chemotherapy for Head and neck squamous cell carcinoma.
- Orbital pseudotumor.
- Smoking status and pain level among Head and neck cancer patients.
- A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal Cancer.
- Elective neck dissection during salvage surgery for locally recurrent Head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation.
- Radiation therapy and hearing loss.
- Definitive radiotherapy for carcinoma in situ of the true vocal cords.
- Definitive radiotherapy for squamous cell carcinoma of the anal canal.
- Outcomes after surgery or definitive radiotherapy for hypopharyngeal Cancer.
- Solitary plasmacytoma.
- Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown Head and neck primary site.
- Radiotherapy in the treatment of resectable rectal adenocarcinoma.
- Radiotherapy for basal cell carcinoma of the medial canthus region.
- Radiation-induced volume changes in parotid and submandibular glands in patients with Head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
- Radiotherapy for cutaneous squamous and basal cell carcinomas of the Head and neck.
- Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
- Radiation effects on the auditory and vestibular systems.
Schools
University Of Florida College Of Medicine
University Fla
Conditions Treated
- Head and Neck Cancer
- Prostate Cancer
- Skin Cancer
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Men's Health
- Top Doctors: Florida
Education
-
University of Florida -
University of South Florida College of Medicine
Hospital
-
UF Health Shands Hospital -
UF Health Jacksonville
Drug Facts
| NPI NUMBER | 1528020708 | |
| NPPES Provider LastName | MENDENHALL | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 381.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 2.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528020708 |
| Last Name Of The Provider | MENDENHALL |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
Lisa McGee
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin I. Holzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Elliott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Amdur, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Judith L. Lightsey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lori A. Grow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Kovacs Jr., MD |
|
Dr. Cherylle A. Hayes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan L. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie C. Greenwalt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Herman, MD |
|
Dr. Christopher J. Balamucki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam L. Holtzman, MD |
|
|
Dr. Kathryn E. Hitchcock, MD
This Doctor is OpenDoctor Recommended.
|